Latest Strategic Investment News

Cardiex has kicked off deliveries of its CONNEQT Pulse arterial health monitors in the U.S., reporting strong preorder momentum and a 150% sales increase in December. The company’s strategic operational shifts and pharma partnerships set the stage for sustained growth in 2025.

Avenira Limited finalised a $4.5 million strategic investment from Hebang Biotechnology and progressed key development milestones at its Wonarah Phosphate Project, signalling a focused push towards near-term production and long-term growth.

Legacy Minerals has secured a $3 million capital raise and reported robust exploration results across several New South Wales projects, including high-grade gold-silver zones at Drake and significant PGE intercepts at Fontenoy. These developments position the company for an active 2025 exploration campaign.

Aldoro Resources has reported robust assay results and significant drilling progress at its Kameelburg REE-Niobium Project in Namibia, underpinning its resource potential and operational momentum.

Carbonxt has marked a pivotal quarter with the mechanical completion of its Kentucky activated carbon plant, a 14% rise in powdered activated carbon sales, and a successful $1.03 million capital raise, setting the stage for stronger revenue growth in 2025.

Altamin Limited has completed its acquisition of Appian's stake in Vedra Metals, gaining 100% ownership of the Gorno Project, while advancing environmental assessments and development plans for its Lazio geothermal lithium project. A recent $3.2 million capital raise underpins its dual strategy to unlock value and progress key assets.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Duxton Farms Limited reported a robust Q2 FY2025, driven by favourable weather conditions and strategic investments, including a share buyback and increased stakes in agricultural ventures. The company recorded a $2.24 million operating cash flow surplus amid mixed crop yields and ongoing diversification.

Greenwing Resources reports significant progress in its lithium and graphite projects, notably expanding the lithium brine footprint at its San Jorge Project in Argentina and advancing exploration in Madagascar amid regulatory shifts.

Alligator Energy reports significant progress across its uranium portfolio, including regulatory milestones at Samphire and promising drilling results at Big Lake and Nabarlek North, supported by a solid cash position of $20.2 million.

Ragnar Metals advances its Swedish exploration with a significant spodumene pegmatite discovery at Orrvik and promising uranium assays at multiple new projects, while strengthening its strategic position through a key investment in Kaiser Reef.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.